Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

Ekso Bionics Holdings, Inc. (EKSO)

Compare
0.4150
+0.0094
+(2.32%)
At close: April 2 at 4:00:01 PM EDT
0.4340
+0.02
+(4.58%)
Pre-Market: 5:12:27 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
17,925
17,925
18,279
12,912
11,246
Cost of Revenue
8,414
8,414
9,200
6,698
4,497
Gross Profit
9,511
9,511
9,079
6,214
6,749
Operating Expense
19,971
19,971
24,191
21,770
20,577
Operating Income
-10,460
-10,460
-15,112
-15,556
-13,828
Net Non Operating Interest Income Expense
-269
-269
-302
-156
-113
Other Income Expense
-601
-601
216
632
4,177
Pretax Income
-11,330
-11,330
-15,198
-15,080
-9,764
Net Income Common Stockholders
-11,330
-11,330
-15,198
-15,080
-9,764
Average Dilution Earnings
--
--
--
--
-1,029
Diluted NI Available to Com Stockholders
-11,330
-11,330
-15,198
-15,080
-10,793
Basic EPS
-0.64
-0.56
-1.10
-1.16
-0.80
Diluted EPS
-0.64
-0.56
-1.10
-1.16
-0.88
Basic Average Shares
17,605.7500
20,161
13,867
12,962
12,193
Diluted Average Shares
17,605.7500
20,161
13,867
12,962
12,269
Total Operating Income as Reported
-10,460
-10,460
-15,112
-15,556
-13,828
Total Expenses
28,385
28,385
33,391
28,468
25,074
Net Income from Continuing & Discontinued Operation
-11,330
-11,330
-15,198
-15,080
-9,764
Normalized Income
-10,730
-10,730
-15,477
-15,742
-13,958
Interest Expense
269
269
302
156
113
Net Interest Income
-269
-269
-302
-156
-113
EBIT
-11,061
-11,061
-14,896
-14,924
-9,651
EBITDA
-9,453
-9,453
-13,198
-14,037
-8,628
Reconciled Cost of Revenue
8,414
8,414
9,200
6,698
4,497
Reconciled Depreciation
1,608
1,608
1,698
887
1,023
Net Income from Continuing Operation Net Minority Interest
-11,330
-11,330
-15,198
-15,080
-9,764
Total Unusual Items Excluding Goodwill
-600
-600
279
662
4,194
Total Unusual Items
-600
-600
279
662
4,194
Normalized EBITDA
-8,853
-8,853
-13,477
-14,699
-12,822
12/31/2021 - 1/17/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MBOT Microbot Medical Inc.
1.7000
+14.09%
 
AVGR Avinger, Inc.
0.4740
-20.74%
 
ZJYL Jin Medical International Ltd.
0.6503
-12.45%
 
AZTA Azenta, Inc.
35.41
+3.78%
 
BLFE BioLife Sciences Inc.
0.0001
0.00%
 
STXS Stereotaxis, Inc.
1.7500
+2.34%
 
TSTL.L Tristel plc
281.90
-1.09%
 
KRMD KORU Medical Systems, Inc.
2.5500
+1.59%
 
INFU InfuSystem Holdings, Inc.
5.32
-0.75%
 
ICUI ICU Medical, Inc.
140.38
+1.87%